Principal Financial Group’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,663
Closed -$232K 2423
2023
Q1
$232K Sell
10,663
-265
-2% -$6.44K ﹤0.01% 2147
2022
Q4
$339K Buy
10,928
+80
+0.7% +$2.26K ﹤0.01% 2072
2022
Q3
$276K Sell
10,848
-8,554
-44% -$201K ﹤0.01% 2105
2022
Q2
$393K Buy
19,402
+4,029
+26% +$89.2K ﹤0.01% 2116
2022
Q1
$380K Sell
15,373
-6,327
-29% -$191K ﹤0.01% 2179
2021
Q4
$754K Buy
+21,700
New +$688K ﹤0.01% 2040
2019
Q3
Sell
-4,146
Closed -$234K 2245
2019
Q2
$234K Sell
4,146
-2,345
-36% -$169K ﹤0.01% 2118
2019
Q1
$474K Buy
6,491
+3,042
+88% +$210K ﹤0.01% 1953
2018
Q4
$220K Sell
3,449
-3,740
-52% -$278K ﹤0.01% 2106
2018
Q3
$717K Buy
7,189
+3,739
+108% +$310K ﹤0.01% 1903
2018
Q2
$245K Sell
3,450
-2,662
-44% -$223K ﹤0.01% 2119
2018
Q1
$637K Buy
6,112
+2,793
+84% +$315K ﹤0.01% 1907
2017
Q4
$334K Buy
+3,319
New +$244K ﹤0.01% 2032

Other funds holding ANAB

Principal Financial Group's ANAB Position: Q2 2023 in Review

Principal Financial Group sold out of AnaptysBio (ANAB) in Q2 2023, closing a stake of 10,663 shares — an estimated $232K sold.

Principal Financial Group first reported a position in ANAB in Q4 2017 and held it in 13 quarters. The position peaked at $754K in Q4 2021. 116 funds tracked by Wall St. Rank hold ANAB as of Q2 2023.

  • Principal Financial Group reported no remaining AnaptysBio position as of Q2 2023 after selling out during the quarter.
  • Principal Financial Group sold 10,663 AnaptysBio shares in Q2 2023, an estimated $232K.
  • Principal Financial Group first reported a position in AnaptysBio in Q4 2017 and held it in 13 quarters.
  • Principal Financial Group's AnaptysBio position peaked at $754K in Q4 2021.
  • 116 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2023.

Based on Principal Financial Group's 13F filing for Q2 2023, filed 7 Aug 2023.